首页> 外文会议>Annual International Conference of the IEEE Engineering in Medicine and Biology Society >A Clinical Decision Support Platform for the Risk Stratification, Diagnosis, and Prediction of Coronary Artery Disease Evolution
【24h】

A Clinical Decision Support Platform for the Risk Stratification, Diagnosis, and Prediction of Coronary Artery Disease Evolution

机译:临床决策支持平台,用于风险分层,诊断和预测冠状动脉疾病的发展

获取原文

摘要

SMARTool aims to perform accurate risk stratification of coronary artery disease patients as well as to provide early diagnosis and prediction of disease progression. This is achieved by the acquisition of data from about 263 patients including computed tomography angiographic images, clinical, molecular, biohumoral, exposome, inflammatory and omics data. Data are collected in two time points with a followup period of approximately 5 years. In the first step, data mining techniques are implemented for the estimation of risk stratification. In the next step, patients, who are classified as medium to high risk are considered for coronary imaging and computational modelling of blood flow, plaque growth and stenosis severity assessment. Additionally, patients with increased stenosis are selected for stent deployment. All the above modules are integrated in a cloud-based platform for the clinical decision support (CDSS) of patients with coronary artery disease. The work presents preliminary results employing the SMARTool dataset as well as the concept and architecture of the under development platform.
机译:SMARTool旨在对冠心病患者进行准确的风险分层,并提供疾病进展的早期诊断和预测。这是通过从大约263名患者中获取数据来实现的,包括计算机断层扫描血管造影图像,临床,分子,生物体液,暴露体,炎性和组学数据。在两个时间点收集数据,随访时间约为5年。第一步,实施数据挖掘技术以评估风险分层。在下一步中,将考虑被分类为中度至高风险的患者进行冠状动脉成像以及血流,斑块生长和狭窄严重程度评估的计算模型。此外,选择狭窄程度更高的患者进行支架部署。以上所有模块均集成在基于云的平台中,用于冠状动脉疾病患者的临床决策支持(CDSS)。这项工作提出了使用SMARTool数据集以及开发平台的概念和体系结构的初步结果。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号